Skip to main content
. 2015 Aug 10;172(19):4741–4756. doi: 10.1111/bph.13248

Figure 7.

Figure 7

EH-201 improved memory performance after i.c.v. injection of Aβ25–35 in mice. (A) Experimental procedure of Aβ25–35 injection and EH-201 treatment. After Aβ25–35-induced memory impairment, mice were fed EH-201 on days 10–24. (B) The memory performance of Aβ25–35-injected mice after EH-201 administration for 1 week (day 17) and 2 weeks (day 24) was measured using a passive avoidance task analysis (n = 5–6). (C, D) EH-201 improved the protein expression of EPO and PGC-1α in the hippocampus (n = 4–5). The values indicate the means ± SEM, #P < 0.05, compared with the control group; *P < 0.05, **P < 0.05, ***P < 0.001, compared with the Aβ25–35-injected only group; Student's t-test.